| Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel NSE Panel Journal of Allergy and Clinical Immunology 126 (6), S1-S58, 2010 | 2119 | 2010 |
| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1734 | 2016 |
| Dupilumab treatment in adults with moderate-to-severe atopic dermatitis LA Beck, D Thaçi, JD Hamilton, NM Graham, T Bieber, R Rocklin, JE Ming, ... New England Journal of Medicine 371 (2), 130-139, 2014 | 1453 | 2014 |
| Cytokine modulation of atopic dermatitis filaggrin skin expression MD Howell, BE Kim, P Gao, AV Grant, M Boguniewicz, A DeBenedetto, ... Journal of Allergy and Clinical Immunology 124 (3), R7-R12, 2009 | 1397 | 2009 |
| Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report JA Boyce, A Assa'ad, AW Burks, SM Jones, HA Sampson, RA Wood, ... Journal of Pediatric Nursing 26 (3), e2-e17, 2011 | 1369 | 2011 |
| Tight junction defects in patients with atopic dermatitis A De Benedetto, NM Rafaels, LY McGirt, AI Ivanov, SN Georas, ... Journal of Allergy and Clinical Immunology 127 (3), 773-786. e7, 2011 | 800 | 2011 |
| Activation of airway epithelial cells by toll-like receptor agonists Q Sha, AQ Truong-Tran, JR Plitt, LA Beck, RP Schleimer American journal of respiratory cell and molecular biology 31 (3), 358-364, 2004 | 639 | 2004 |
| Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel A Togias, SF Cooper, ML Acebal, A Assa’ad, JR Baker, LA Beck, J Block, ... World Allergy Organization Journal 10, 1-18, 2017 | 636 | 2017 |
| Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose … D Thaci, EL Simpson, LA Beck, T Bieber, A Blauvelt, K Papp, W Soong, ... The Lancet 387 (10013), 40-52, 2016 | 619 | 2016 |
| Atopic dermatitis: a practice parameter update 2012 L Schneider, S Tilles, P Lio, M Boguniewicz, L Beck, J LeBovidge, ... Journal of Allergy and Clinical Immunology 131 (2), 295-299. e27, 2013 | 553 | 2013 |
| Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by ex Vivo Granulocyte-Macrophage Colony-stimulating Factor Gene Transfer JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ... Cancer research 57 (8), 1537-1546, 1997 | 533 | 1997 |
| Omalizumab-induced reductions in mast cell FcεRI expression and function LA Beck, GV Marcotte, D MacGlashan Jr, A Togias, S Saini Journal of Allergy and Clinical Immunology 114 (3), 527-530, 2004 | 524 | 2004 |
| Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes JK Garrett, SC Jameson, B Thomson, MH Collins, LE Wagoner, ... Journal of Allergy and Clinical Immunology 113 (1), 115-119, 2004 | 492 | 2004 |
| Atopic dermatitis: a disease caused by innate immune defects? A De Benedetto, R Agnihothri, LY McGirt, LG Bankova, LA Beck Journal of Investigative Dermatology 129 (1), 14-30, 2009 | 453 | 2009 |
| Chemokines: key players in innate and adaptive immunity C Esche, C Stellato, LA Beck Journal of Investigative Dermatology 125 (4), 615-628, 2005 | 453 | 2005 |
| Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial EL Simpson, AS Paller, EC Siegfried, M Boguniewicz, L Sher, ... JAMA dermatology 156 (1), 44-56, 2020 | 405 | 2020 |
| Skin barrier disruption: a requirement for allergen sensitization? A De Benedetto, A Kubo, LA Beck Journal of Investigative Dermatology 132 (3), 949-963, 2012 | 399 | 2012 |
| Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials EL Simpson, JP Lacour, L Spelman, R Galimberti, LF Eichenfield, ... British Journal of Dermatology 183 (2), 242-255, 2020 | 393 | 2020 |
| Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial E Guttman-Yassky, D Thaçi, AL Pangan, HC Hong, KA Papp, K Reich, ... Journal of Allergy and Clinical Immunology 145 (3), 877-884, 2020 | 327 | 2020 |
| Atopic dermatitis and asthma: parallels in the evolution of treatment LF Eichenfield, JM Hanifin, LA Beck, RF Lemanske Jr, HA Sampson, ... Pediatrics 111 (3), 608-616, 2003 | 321 | 2003 |
